迟做总比不做好——症状性肋骨骨折及骨不连延迟肋骨固定的单中心回顾
该单中心回顾性研究纳入2017年1月至2022年9月间因症状性肋骨骨折骨不连在门诊接受延迟SSRF(定义为伤后超过2周)的44例患者,共156处症状性骨不连肋骨骨折。平均年龄59.2±11.9岁,伤后至SSRF中位时间172.5天(IQR 27.5-200),平均每例固定3.5±1.8根肋骨。术后疼痛评分从术前6.8±1.9降至2.02±1.5(p<0.001),93.2%患者胸壁不稳定及术前症状缓解(p<0.001),仅3例术后入ICU且不超过2天,中位住院时间2天(IQR 1-3天),2例(4.5%)出现术后并发症经再次手术干预后缓解。作者认为延迟SSRF安全,可显著缓解术前症状。
要点
- 延迟SSRF定义为伤后超过2周在门诊进行;本研究伤后至手术中位时间172.5天(IQR 27.5-200)。
- 44例患者共156处症状性骨不连肋骨骨折接受延迟SSRF,平均每例固定3.5±1.8根肋骨。
- 术后平均疼痛评分从术前6.8±1.9降至2.02±1.5(p<0.001)。
- 93.2%患者术后胸壁不稳定及术前症状缓解(p<0.001)。
- 仅3例术后入ICU且不超过2天,中位住院时间2天(IQR 1-3天);2例(4.5%)出现术后并发症,经再次手术干预后缓解。
适用人群与场景
- 2017年1月至2022年9月在一级创伤中心就诊、因症状性肋骨骨折骨不连接受延迟SSRF的患者。
- 延迟SSRF定义为伤后超过2周在门诊进行的手术固定。
诊断标准与关键阈值
- 延迟SSRF定义:伤后超过2周在门诊进行的手术固定。
处置流程与药物剂量
- 延迟SSRF:伤后超过2周在门诊进行手术固定,平均每例固定3.5±1.8根肋骨。
研究设计与关键结果
- 研究类型:单中心回顾性研究;样本量44例,共156处症状性骨不连肋骨骨折接受延迟SSRF。
- 平均年龄59.2±11.9岁;伤后至SSRF中位时间172.5天(IQR 27.5-200)。
- 平均每例固定肋骨数3.5±1.8根。
- 术后仅3例入ICU且不超过2天;中位住院时间2天(IQR 1-3天)。
- 平均疼痛评分:术前6.8±1.9 vs 术后2.02±1.5(p<0.001)。
- 93.2%患者术后胸壁不稳定及术前症状缓解(p<0.001)。
- 2例(4.5%)出现术后并发症,经再次手术干预后缓解。
- 术后随访影像学显示肋骨骨折愈合。
证据类型、等级与局限
- 证据类型:单中心回顾性研究;证据等级:治疗/护理管理;Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为延迟SSRF安全,可显著缓解术前症状(降低疼痛、改善胸壁稳定性、恢复日常生活活动能力)。
- 适用人群:伤后超过2周、存在症状性肋骨骨折骨不连的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Surgical stabilization of rib fractures (SSRFs) has become an emerging therapy for treatment of patients with rib fractures. More commonly, it is used in the acute setting; however, delayed SSRF can be utilized for symptomatic rib fracture nonunions. Here, we describe our institution's experience with delayed SSRF, hypothesizing it is safe and resolves patient symptoms.
METHODS: This is a retrospective review of patients presenting to our Level I trauma center to undergo delayed SSRF for symptomatic nonunions from January 2017 to September 2022. Delayed SSRF was defined as SSRF over 2 weeks in the outpatient setting. Basic demographics were obtained. Outcomes of interest included mean pain score (preoperatively and postoperatively), intensive care unit (ICU) and hospital length of stay (LOS), and resolution of preoperative symptoms, specifically chest wall instability, with return to activities of daily living (ADLs).
RESULTS: Forty-four patients met inclusion criteria with a total of 156 symptomatic nonunion rib fractures that received delayed SSRF. The average age was 59.2 ± 11.9 years and median number of days from injury to SSRF was 172.5 (interquartile range, 27.5-200). The average number rib fractures plated per patient 3.5 ± 1.8. Only three patients required ICU admission postoperatively for no longer than 2 days. Median hospital LOS was 2 days (interquartile range 1-3 days). Average preoperative and postoperative pain score was 6.8 ± 1.9 and 2.02 ± 1.5, respectively ( p < 0.001). Chest wall instability and preoperative symptoms resolved in 93.2% of patients postoperatively ( p < 0.001). Two patients (4.5%) had postoperative complications that resolved after additional surgical intervention. Rib fracture healing was demonstrated on radiographic imaging during postoperative follow-up.
CONCLUSION: Delayed SSRF is safe and demonstrates significant resolution of preoperative symptoms by decreasing pain, improving chest wall stability, and allowing patients to return to activities of daily living.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Bauman ZM, Khan H, Cavlovic L, et al. Better late than never-a single-center review of delayed rib fixation for symptomatic rib fractures and nonunions. J Trauma Acute Care Surg. 2023. PMID: 37697466. doi:10.1097/TA.0000000000004136
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。